Impact of COVID-19 on oncological outcomes during follow-up in gynaecological cancer: A nationwide retrospective cohort study
This study demonstrates that two-year RFS and two-year OS during follow-up after treatment for a gynaecologic malignancy were not impacted by the follow-up care, as provided during the COVID-19 pandemic. These findings indicate that adaptations in follow-up care during the COVID-19 pandemic were not associated with worse oncological outcomes, warranting further investigation into more flexible follow-up strategies.
Authors
- Bfm Slangen
- LRCW van Lonkhuijzen
- M.A. van der Aa
- H.H.B. Wenzel
- J.W.M. Aarts
- M. Snijders
- E.M. Vermaas
Institutions
- Maastricht University Medical Centre (NL)
- Netherlands Comprehensive Cancer Organisation (NL)
- Vrije Universiteit Amsterdam (NL)
Publication Details
- Journal
- Gynecologic Oncology
- Published
- 2026-01-20
- DOI
- https://doi.org/10.1016/j.ygyno.2026.01.002
- Primary Topic
- COVID-19 and healthcare impacts
- Type
- article
- Field-Weighted Citation Impact
- 0.00